HIV medication subject to tenders
The Norwegian parliament has decided that medicines supplied through the hospitals shall be subject to a tender in order to reduce costs. This also applies to drugs for treating HIV infection. Hospitals are obliged to prescribe those medicines that won the tender.
In November 2022 results from the third round of tenders were announced. This time HivNorway is pleased with the outcome. Two significant positive outcomes from this round of tenders is that the medications on the list are all combination tablets, or single tablets. Secondly, there is equal recommendations from the national guidelines for hiv treatment and the outcome of the medication subject to tenders. This time it is also more clearly spesified that any medical reasons why a person should be prescribed medication different from what is on the list, can be justified in the patients records. It is therefore important that you have a close and open dialogue with your medical doctor so you can receive the most appropriate medication taking into consideration guidelines, cost, overall health and wellbeing.
These are the combinations that won the tender in 2022:
- Delstrigo (doravirin/lamivudine/tenofovir disproksil)
- Dovato (dolutegravir/lamivudine)
- Triumeq (dolutegravir/abacavir/lamivudine)
- Biktarvy (biktegravir/emtricitabine/TAF)
Genvoya, a medication commonly used, shall be changed to other medications as it is no longer among the recommended tablets.
If you have any other questions or need assistance, please do not hesitate to contact us. You can reach us by phone 21314580, via Messenger, on our Facebook page (HivNorge) or via email.
Les også
schedule27.11.2025
→ Kutt i bistand kan føre til at flere millioner blir smittet med hiv
UNAIDS lanserer i forbindelse med verdens aidsdag 1. desember en ny rapport som viser at kutt i bistandspenger går utover bekjempelsen av hiv og aids. – Den globale responsen mot hiv har blitt påført den største tilbakegangen på flere tiår, sier UNAIDS-sjef Winnie Byanyima, i forbindelse med lanseringen av rapporten.
schedule27.11.2025
→ – Støtte til Det globale fondet er en investering i vår egen helsesikkerhet
Statsminister Jonas Gahr Støre deltok fredag 21. november på den åttende påfyllingskonferansen for Det globale fondet for bekjempelse av aids, tuberkulose og malaria. Konferansen fant sted under G20-toppmøtet i Johannesburg. Målet for konferansen er å redde 23 millioner liv gjennom redusert dødelighet av de tre sykdommene.